University of California San Diego

Aversion to Risk by R&D Managers May Hurt U.S. Economic Prospects

Executives tolerant of failure in pursuit of reward are best suited to seed innovation needed for growth
16-Mar-2020 3:30 PM EDT, by University of California San Diego

Newswise — While concerns loom over an impending recession caused by the spread of COVID-19, policymakers and business leaders have implemented radical strategies, such as slashing interest rates to invigorate the U.S.’s weakened economy.  Research and Development (R&D) has long been key in the nation’s economic prospects and according to new research from the University of California San Diego, the country’s ability to maintain its competitive edge in this area largely depends on managers in R&D being less averse to risk.

R&D is important for the success of companies and is essential in boosting economic growth; however, it is generally an expensive and complex undertaking. For example, the decline in new drugs and breakthrough therapeutics—despite increased R&D spending—has been attributed in part to a lack of risk-taking by pharmaceutical and biotech companies. This has been cause for concern among research and investor communities, who point to slowdowns of paradigm-shifting discoveries in the past quarter century.

According to the authors of a National Bureau of Economic Research (NBER) working paper, encouraging appropriate risk-taking is the key to successful R&D programs. However, their research shows that the required tolerance of failure in pursuit of reward is not a disposition that is equally shared across R&D managers, which is troublesome for the advancement of science.

The paper’s co-author, Joshua Graff Zivin, a professor of economics with UC San Diego’s School of Global Policy and Strategy gives an example of how the risky exploration of unproven scientific pathways led to the discovery of immunotherapy’s now-heralded role in cancer treatment.

“When immunologist James Allison developed an antibody that he felt was ready for pharmaceutical development, biotech companies repeatedly turned him away after dismissing his ideas as too farfetched,” Graff Zivin said. “However, he persevered and today, drugs based on his initial ideas are now poised to become among the most clinically and commercially successful cancer drugs on the market.”

He added, outside-the-box decision-making can aid in the race to develop a vaccine to stop the spread of COVID-19.

Why firms should recruit R&D managers who have an “appetite for risk”

To understand how managers respond to risk when making R&D decisions, the researchers conducted a series of experiments with master’s degree students in a program focused on the intersection of business and technology. Many of these students go on to work at investment firms or serve as managers making R&D decisions at companies in the health and technology sectors.

The nearly 200 MBA and Master of Finance participants from UC San Diego’s Rady School of Management were asked to assume the role of a R&D director at a private company. In a tournament-style structure, students had to “bet” on their preferred research projects from a series of hypothetical proposals that had been judged and scored by an objective, outside science advisory panel. The proposals were scored on a scale of high-variance projects (i.e. with riskier outcomes) and low-variance projects (i.e. with more predicable outcomes).

The experiments provided financial rewards that disproportionately encouraged the choice of riskier projects. Despite this, participants routinely chose the low-variance investments, consistently showing a distaste for projects that had greater uncertainty.

In another experiment with the same group, students were randomly assigned a budget and were asked to invest in a simulated portfolio where again they had to choose between risky and non-risky projects to invest in. Much to the researchers’ surprise, participants again consistently chose to invest in projects with the safest outcomes, especially among those with smaller budgets.

“Though our participants are trained and incentivized to take on more risk in exchange for more reward, they did not behave this way,” Graff Zivin said. “Our study points to potential inefficiencies in the research investment process, and the results could help explain low rates of breakthrough innovation.”

Who among the group were most comfortable with risk-taking enterprises? Of the subjects, 52 percent were classified as risk-averse, 36 percent were risk-neutral and 12 percent were risk-loving. They found that decision-makers who are risk-loving were most likely to fund breakthrough projects.

The authors concluded, “Our results showing that participants ‘hard-wired’ as risk-loving made better investment decisions indicates that firms aiming to encourage more innovation may want to include the risk preferences of those workers in charge of research and development as a factor in their hiring and promotion decisions.”

Graff Zivin’s co-authors include Richard T. Carson, professor of economics in the UC San Diego Division of Social Sciences; Jordan J. Louviere, professor of marketing, School of Marketing, University of South Australia; Sally Sadoff, professor of economics, UC San Diego’s Rady School of Management; and Jeffrey G. Shrader, assistant professor of economics, School of International and Public Affairs, Columbia University.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 1929
Released: 26-May-2020 7:30 PM EDT
Dementia gene raises risk of severe COVID-19
University of Exeter

Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.

Released: 26-May-2020 4:00 PM EDT
#FitForTheFrontLine Challenge Unites Nation’s Top Medical Centers in Support of Front-Line Health Care Workers
Mount Sinai Health System

Fitness challenge honors and supports health care heroes at Mount Sinai Health System and Academic Centers Across the Country. Goldman Sachs & Co., Peloton, Discovery, NBCUniversal Owned Television Stations, dtx and Pinterest Support First-Ever Collective Medical Center Campaign.

Newswise: 232760_web.jpg
Released: 26-May-2020 3:15 PM EDT
Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in The New England Journal of Medicine.

Released: 26-May-2020 3:10 PM EDT
High Rates of COVID-19 on American Indian Reservations – Water and Language Barriers Affect Risk
Wolters Kluwer Health: Lippincott Williams and Wilkins

Early in the pandemic, American Indian Reservations have experienced a disproportionately high incidence of COVID-19 infections: four times higher than in the US population, reports a study in the July/August issue of the Journal of Public Health Management and Practice. The special issue of JPHMP focuses on COVID-19, with commentaries and scientific articles describing the pandemic in the United States and globally. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise:Video Embedded covid-19-a-wake-up-call-for-the-need-for-new-antiviral-weapons
VIDEO
Released: 26-May-2020 3:00 PM EDT
COVID-19: A wake-up call for the need for new antiviral weapons
Morgridge Institute for Research

Even after heroic medical and societal efforts finally break the back of the current COVID-19 pandemic, the global sigh of relief may not last long. The chilling reality is that viral threats are growing more common. And they’re getting deadlier.

Newswise: Experts available to comment on racial and social inequality in COVID-19 health care
Released: 26-May-2020 12:55 PM EDT
Experts available to comment on racial and social inequality in COVID-19 health care
Indiana University

As all 50 U.S. states ease economic restrictions implemented in response to the coronavirus, health and policy experts are braced for a potential second wave of COVID-19. Based on the first phase of the crisis, the hardest-hit populations are anticipated among communities of color, which have been disproportionally affected. According to a recent report from American Public Media Research Lab, African Americans are more than twice as likely to die from COVID-19 as Latino or Asian Americans, and nearly 2 1/2 times as likely as whites. Indiana University experts on racial inequality, social inequality in health care and demographics data are available to comment on these topics.

26-May-2020 12:15 PM EDT
UCLA receives $1 million for COVID-19 Rapid Response Initiative
UCLA Fielding School of Public Health

A $1 million gift from the Shurl and Kay Curci Foundation will support the UCLA COVID-19 Rapid Response Initiative, a partnership of the UCLA Fielding School of Public Health and the David Geffen School of Medicine at UCLA.


Showing results

110 of 1929

close
0.61495